Therapeutic options for 5-lipoxygenase inhibitors

O Werz, D Steinhilber - Pharmacology & therapeutics, 2006 - Elsevier
5-Lipoxygenase (5-LO) catalyzes the conversion of arachidonic acid (AA) into leukotriene
(LT) A4 and 5-hydroperoxyeicosatetraenoic acid. LTA4 can then be converted into LTB4 by …

Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin

N Li, X Chen, J Liao, G Yang, S Wang… - …, 2002 - academic.oup.com
Tea is one of the most popular beverages consumed in the world. Curcumin, the major
yellow pigment in turmeric, is used widely as a spice and food-coloring agent. In this study …

[HTML][HTML] Cysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancer

S Savari, K Vinnakota, Y Zhang… - World journal of …, 2014 - ncbi.nlm.nih.gov
Long-standing inflammation has emerged as a hallmark of neoplastic transformation of
epithelial cells and may be a limiting factor of successful conventional tumor therapies. A …

Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib

N Li, S Sood, S Wang, M Fang, P Wang, Z Sun… - Clinical cancer …, 2005 - AACR
Purpose: Previous studies have suggested an important role of aberrant arachidonic acid
metabolism, especially the cyclooxygenase (Cox) pathway, in oral carcinogenesis …

LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways

WG Tong, XZ Ding, MS Talamonti, RH Bell… - … and biophysical research …, 2005 - Elsevier
We have previously shown the importance of LTB4 in human pancreatic cancer. LTB4
receptor antagonists block growth and induce apoptosis in pancreatic cancer cells both in …

Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells

WG Tong, XZ Ding, R Hennig, RC Witt, J Standop… - Clinical Cancer …, 2002 - AACR
Purpose: The effects of leukotriene (LT) B4 and its receptorantagonist LY293111 on
proliferation and apoptosis of human pancreatic cancer cells were investigated, both in vitro …

Leukotriene A4 hydrolase as a target for cancer prevention and therapy

X Chen, S Wang, N Wu, CS Yang - Current cancer drug targets, 2004 - ingentaconnect.com
Leukotriene A4 hydrolase (LTA4H) is a bifunctional zinc enzyme with the activities of
epoxide hydrolase and aminopeptidase. As an epoxide hydrolase, LTA4H catalyzes the …

BLT2 promotes the invasion and metastasis of aggressive bladder cancer cells through a reactive oxygen species-linked pathway

EY Kim, JM Seo, C Kim, JE Lee, KM Lee… - Free Radical Biology and …, 2010 - Elsevier
Aggressive bladder cancer is a major cause of morbidity and mortality. Despite the fact that
metastatic disease results in death in the majority of bladder cancer cases, the molecular …

Targeting LTA4H facilitates the reshaping of the immune microenvironment mediated by CCL5 and sensitizes ovarian cancer to Cisplatin

Z Guo, J Huang, X Huo, C Huang, X Yu, Y Sun… - Science China Life …, 2024 - Springer
Ovarian cancer is the most lethal and aggressive gynecological cancer with a high
recurrence rate and is often diagnosed late. In ovarian cancer, multiple metabolic enzymes …

Current status of the use of multifunctional enzymes as anti-cancer drug targets

CSS Teixeira, SF Sousa - Pharmaceutics, 2021 - mdpi.com
Fighting cancer is one of the major challenges of the 21st century. Among recently proposed
treatments, molecular-targeted therapies are attracting particular attention. The potential …